Laboratory Biomarkers and Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS)

RecruitingOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

November 27, 2023

Primary Completion Date

April 30, 2027

Study Completion Date

July 31, 2027

Conditions
Acute Respiratory Distress SyndromeBarotrauma
Interventions
DIAGNOSTIC_TEST

Blood and bronchoalveolar fluid collection and analysis

Blood and bronchoalveolar lavage fluid will be collected within 12 hours after intubation. Blood samples will be centrifuged, and the serum immediately stored at less than 70° C. The following biomarkers will be analysed in the serum and bronchoalveolar lavage fluid: Interleukin-8 (IL-8), Interleukin (IL)-6, IL-1Ra, IL-18, interferon (IFN ), Angiopoietin-2 (Ang-2), Tumour Necrosis Factor receptor-1 (TNFr1), Plasminogen Activator Inhibitor-1(PAI-1), Receptor for Advanced Glycation Endproducts (RAGE), Intercellular adhesion molecule-1 (ICAM-1), Surfactant Protein D (SPD), protein C, Von Willebrand Factor (VWF), CXCL10/CXCR3, and metalloproteases (MMP9, MMP10). Blood samples obtained from the patients will be placed in specimen tubes containing heparin, centrifuged at 1500 G for 10 minutes, and then the plasma will be aspirated and stored at -70° C. Bronchoalveolar lavage fluid will be centrifuged at 1500 G for 10 minutes to remove cellular contents and stored at -70° C.

DIAGNOSTIC_TEST

Chest CT scan

Computed Tomography Scan per normal clinical practice

Trial Locations (4)

20132

RECRUITING

IRCCS San Raffaele Scientific Institute, Milan

Unknown

NOT_YET_RECRUITING

A.O.U. di Cagliari, Cagliari

NOT_YET_RECRUITING

A.O.U. Pisana, Pisa

NOT_YET_RECRUITING

Ospedale San Carlo, Potenza

All Listed Sponsors
lead

Università Vita-Salute San Raffaele

OTHER